Immunoactive ionic liquids based
on 2-hydroxyethylamines and 1-R-indol-3-ylsulfanylacetic acids. Crystal
and molecular structure of immunodepressant tris-(2-hydroxyethyl)ammonium
indol-3-ylsulfanylacetate

• Authors: Anna N. Mirskova , Sergey N. Adamovich , Rudolf G. Mirskov , Olga P. Kolesnikova , Uwe Schilde
• Languages of publication: EN

Abstracts

EN

Keywords

EN

Protic 2-hydroxyethylammonium ionic liquids; 2-Hydroxyethylammonium 1-R-indol-3-ylsulfanylacetates; Crystal and molecular structure; Immunoactive properties

• Publisher: De Gruyter Open
• Journal: Open Chemistry
• Year: 2015
• Volume: 13
• Issue: 1

Dates

online

1 - 11 - 2014

received

15 - 4 - 2014

accepted

17 - 6 - 2014

Contributors

author

Anna N. Mirskova

• A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 664033 Irkutsk, Russia

author

Sergey N. Adamovich

• A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 664033 Irkutsk, Russia

author

Rudolf G. Mirskov

• A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 664033 Irkutsk, Russia

author

Olga P. Kolesnikova

• Research Institute of Clinical Immunology, Siberian Branch of the Russian Academy of Medical Sciences, 630099 Novosibirsk, Russia

author

Uwe Schilde

• Institute of Chemistry, University of Potsdam, D-14476 Potsdam, Germany

References

• [1] Hough W.L., Smiglak M., Rodrıґguez H., Swatloski R.P.,Spear S.K., Daly D.T., et al., New J. Chem., 2007, 31, 1429, DOI: 10.1039/B706677P[Crossref]
• [2] Fukaya Y., Iizuka Y., Sekihawa K., Ohno H., Green Chem. 2007, 9, 1155, DOI: 10.1039/B706571J[Crossref]
• [3] Hough W.L., Rogers R.D., Bull. Chem. Soc. Jpn., 2007, 80(12), 2262, DOI:10.1246/bcsj.80.2262[Crossref]
• [4] Rodríguez H., Bica K., Rogers R.D., Trop. J. Pharm. Res., 2008, 7, 1011
• [5] Stoimenovski J., MacFarlane D.R., Bica K., Rogers R.D., Pharm. Research., 2010, 27(4), 521, DOI: 10.1007/s11095-009-0030-0[Crossref]
• [6] Kumar V., Malhotra S.V., in: Malhotra S.V. (Ed.), Ionic Liquid Applications: Pharmaceuticals, Therapeutics and Biotechnology, ACS Symposium Series, Washington, 2010, 1038, 1, DOI: 10.1021/bk-2010-1038.ch001[Crossref]
• [7] Petkovic M., Seddon K.R., Rebelo L.P.N., Pereira C.S., Chem. Soc. Rev., 2011, 40(3), 1403, DOI: 10.1039/C004968A[Crossref]
• [8] Stoimenovski J., MacFarlane D.R., Chem. Commun., 2011, 47, 11429, DOI: 10.1039/C1CC14314J[Crossref]
• [9] Stoimenovski J., Dean P.M., Izgorodina E.I., MacFarlane D.R., Faraday Discuss, 2012, 154, 335, DOI:10.1039/C1FD00071C[Crossref]
• [10] Seter M., Thomson M.J., Stoimenovski J., MacFarlane D.R., Forsyth M., Chem. Commun., 2012, 48, 5983, DOI: 10.1039/c2cc32375c[Crossref]
• [11] Mirskova A.N., Mirskov R.G., Adamovich S.N., Voronkov M.G., Russ. J. Chemistry for Sustainable Development, 2011, 19, 467
• [12] Mirskova A.N., Levkovskaja G.G., Mirskov R.G., Voronkov M.G., Russ. J. Org Chem., 2008, 44, 1478
• [13] Mirskova A.N., Levkovskaya G.G., Kolesnikova O.P., Perminova O.M., Rudyakova E.V., Adamovich S.N., Russian Chem. Bull., 2010, 59(12), 2236, DOI: 1066-5285/10/5912-2236
• [14] Sheldrick G.M., SHELXS-97: Program for the Solution of Crystal Structures, University of Göttingen, Germany, 1997
• [15] Sheldrick G.M., SHELXL-2013, Program for the Refinement of Crystal Structures, University of Göttingen, Germany, 2013
• [16] Brandenburg K., DIAMOND, Version 3.1, Crystal Impact, Bonn, 2005
• [17] Levkovskaya G.G., Rudyakova E.V., Mirskova A.N., Russ. J. Org. Chem., 2002, 38, 1478

Identifiers

DOI

10.1515/chem-2015-0018